Variant report

Variant	nsv970092
Chromosome Location	chr6:27177750-27181734
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:225)
CpG islands
(count:305)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:225 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:27177483-27177785	K562	blood:	n/a	n/a
2	ARID3A	chr6:27180763-27181108	K562	blood:	n/a	n/a
3	ARID3A	chr6:27181535-27181867	K562	blood:	n/a	n/a
4	ATF1	chr6:27181562-27181809	K562	blood:	n/a	n/a
5	ATF3	chr6:27181327-27181979	K562	blood:	n/a	n/a
6	ATF3	chr6:27177407-27177956	K562	blood:	n/a	n/a
7	ATF3	chr6:27181337-27182009	A549	lung:	n/a	n/a
8	ATF3	chr6:27177353-27178009	A549	lung:	n/a	n/a
9	ATF3	chr6:27177377-27177964	A549	lung:	n/a	n/a
10	ATF3	chr6:27181235-27182014	A549	lung:	n/a	n/a
11	BATF	chr6:27181506-27181715	GM12878	blood:	n/a	n/a
12	BATF	chr6:27181556-27181715	GM12878	blood:	n/a	n/a
13	BDP1	chr6:27177411-27177777	K562	blood:	n/a	n/a
14	BDP1	chr6:27181525-27181936	K562	blood:	n/a	n/a
15	BHLHE40	chr6:27181570-27181784	K562	blood:	n/a	n/a
16	BHLHE40	chr6:27181086-27181172	K562	blood:	n/a	n/a
17	BRCA1	chr6:27179267-27179276	H1-hESC	embryonic stem cell:	n/a	n/a
18	CBX3	chr6:27180721-27183195	K562	blood:	n/a	n/a
19	CBX3	chr6:27177388-27177870	K562	blood:	n/a	n/a
20	CBX3	chr6:27181223-27181867	K562	blood:	n/a	n/a
21	CEBPB	chr6:27181516-27181868	H1-hESC	embryonic stem cell:	n/a	n/a
22	CEBPB	chr6:27177416-27177828	K562	blood:	n/a	n/a
23	CEBPB	chr6:27177601-27177995	H1-hESC	embryonic stem cell:	n/a	n/a
24	CEBPB	chr6:27180786-27181255	K562	blood:	n/a	n/a
25	CEBPB	chr6:27181025-27181054	K562	blood:	n/a	n/a
26	CEBPB	chr6:27181573-27181825	K562	blood:	n/a	n/a
27	CEBPB	chr6:27177842-27178063	A549	lung:	n/a	n/a
28	CEBPB	chr6:27181563-27181847	A549	lung:	n/a	n/a
29	CEBPB	chr6:27181478-27181891	MCF-7	breast:	n/a	n/a
30	CEBPB	chr6:27181505-27181873	A549	lung:	n/a	n/a
31	CEBPB	chr6:27181275-27181920	K562	blood:	n/a	n/a
32	CEBPB	chr6:27181506-27181891	K562	blood:	n/a	n/a
33	CEBPB	chr6:27181347-27181952	A549	lung:	n/a	n/a
34	CHD2	chr6:27177534-27177787	K562	blood:	n/a	n/a
35	CHD2	chr6:27181500-27181805	K562	blood:	n/a	n/a
36	CREB1	chr6:27181431-27181791	A549	lung:	n/a	n/a
37	CREB1	chr6:27181497-27181873	K562	blood:	n/a	n/a
38	CREB1	chr6:27181610-27181740	A549	lung:	n/a	n/a
39	CREB1	chr6:27177560-27177809	A549	lung:	n/a	n/a
40	CREB1	chr6:27181412-27181940	K562	blood:	n/a	n/a
41	CTCF	chr6:27180820-27180970	HCT-116	colon:	n/a	n/a
42	CTCF	chr6:27180939-27181050	GM19238	blood:	n/a	n/a
43	CTCF	chr6:27180820-27180970	HMEC	breast:	n/a	n/a
44	CTCF	chr6:27180928-27181060	GM12878	blood:	n/a	n/a
45	CTCF	chr6:27180760-27180910	A549	lung:	n/a	n/a
46	CTCF	chr6:27180693-27181127	K562	blood:	n/a	n/a
47	CTCF	chr6:27180740-27180890	HFF-Myc	foreskin:	n/a	n/a
48	CTCF	chr6:27180923-27181048	MCF-7	breast:	n/a	n/a
49	CTCF	chr6:27180920-27181070	HBMEC	blood vessel:	n/a	n/a
50	CTCF	chr6:27180780-27180930	K562	blood:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:27179116-27179166	HMEC	breast:	n/a
2	chr6:27179032-27179082	SK-N-SH	brain:	n/a
3	chr6:27179116-27179166	AG04450	lung:	fetal
4	chr6:27179037-27179087	AG09319	gingival:	n/a
5	chr6:27181670-27181720	HCM	heart:	n/a
6	chr6:27179116-27179166	HL-60	blood:	n/a
7	chr6:27179037-27179087	BJ	skin:	n/a
8	chr6:27179116-27179166	BJ	skin:	n/a
9	chr6:27179037-27179087	Caco-2	colon:	n/a
10	chr6:27181670-27181720	Jurkat	blood:	n/a
11	chr6:27181670-27181720	Caco-2	colon:	n/a
12	chr6:27179116-27179166	HCF	heart:	n/a
13	chr6:27181670-27181720	AG10803	skin:	n/a
14	chr6:27179032-27179082	HCT-116	colon:	n/a
15	chr6:27179035-27179085	HL-60	blood:	n/a
16	chr6:27179035-27179085	AG04449	skin:	fetal
17	chr6:27179116-27179166	PANC-1	pancreas:	n/a
18	chr6:27179032-27179082	ECC-1	luminal epithelium:	n/a
19	chr6:27179032-27179082	GM12891	blood:	n/a
20	chr6:27181670-27181720	NB4	blood:	n/a
21	chr6:27179037-27179087	HCPEpiC	choroid plexus:	n/a
22	chr6:27179035-27179085	HRE	kidney:	n/a
23	chr6:27179037-27179087	HCT-116	colon:	n/a
24	chr6:27179037-27179087	HRCEpiC	kidney:	n/a
25	chr6:27179037-27179087	MCF10A-Er-Src	breast:	n/a
26	chr6:27179035-27179085	K562	blood:	n/a
27	chr6:27179037-27179087	HPAEpiC	pulmonary alveolar:	n/a
28	chr6:27181670-27181720	PANC-1	pancreas:	n/a
29	chr6:27179032-27179082	HEEpiC	esophagus:	n/a
30	chr6:27179035-27179085	SK-N-MC	brain:	n/a
31	chr6:27179116-27179166	ovcar-3	ovarian:	n/a
32	chr6:27179116-27179166	AG09319	gingival:	n/a
33	chr6:27179032-27179082	NH-A	brain:	n/a
34	chr6:27179037-27179087	HCM	heart:	n/a
35	chr6:27179035-27179085	H1-hESC	embryonic stem cell:	embryo
36	chr6:27179037-27179087	Hela-S3	cervix:	n/a
37	chr6:27181670-27181720	HIPEpiC	eye:	n/a
38	chr6:27181670-27181720	MCF10A-Er-Src	breast:	n/a
39	chr6:27179037-27179087	SK-N-SH_RA	brain:	n/a
40	chr6:27179032-27179082	GM12892	blood:	n/a
41	chr6:27179116-27179166	A549	lung:	n/a
42	chr6:27179032-27179082	HNPCEpiC	eye:	n/a
43	chr6:27179035-27179085	HepG2	liver:	n/a
44	chr6:27179116-27179166	AoSMC	blood vessel:	n/a
45	chr6:27179035-27179085	HCT-116	colon:	n/a
46	chr6:27179116-27179166	BE2_C	brain:	n/a
47	chr6:27179035-27179085	NHBE	bronchial:	n/a
48	chr6:27179116-27179166	T-47D	breast:	n/a
49	chr6:27179037-27179087	HNPCEpiC	eye:	n/a
50	chr6:27179035-27179085	RPTEC	kidney:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:27171746..27174029-chr6:27180862..27184062,3	K562	blood:
2	chr6:27178603..27181453-chr6:27860902..27863574,2	K562	blood:
3	chr6:27180410..27183242-chr6:27519204..27521142,2	K562	blood:
4	chr6:27177161..27179137-chr6:27326485..27328754,2	K562	blood:
5	chr6:27113325..27119101-chr6:27172973..27177922,8	K562	blood:
6	chr6:27179126..27181346-chr6:27660529..27662958,2	K562	blood:
7	chr6:27180877..27182881-chr6:27262753..27266056,3	K562	blood:
8	chr6:27180369..27183815-chr6:27439308..27442390,4	K562	blood:

No data

Variant related genes	Relation type
ENSG00000174572	TF binding region
ENSG00000174572	CpG island
ENSG00000196331	chromatin interactions
ENSG00000265565	chromatin interactions
ENSG00000184825	chromatin interactions
ENSG00000096654	chromatin interactions
ENSG00000233224	chromatin interactions
ENSG00000197903	chromatin interactions
ENSG00000204789	chromatin interactions

Extended variants
information (count: 182 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:182 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs533219984	chr6:27177758-27177759	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs140780540	chr6:27177760-27177761	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs528833372	chr6:27177764-27177765	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs537759356	chr6:27177907-27177908	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs114061873	chr6:27177929-27177930	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs150101881	chr6:27177942-27177943	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs533900230	chr6:27177948-27177949	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs78854959	chr6:27177964-27177965	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs858985	chr6:27178028-27178029	Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
10	rs576885616	chr6:27178038-27178039	Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs539489800	chr6:27178059-27178060	Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs576767035	chr6:27178077-27178078	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs188714660	chr6:27178093-27178094	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs556202350	chr6:27178192-27178193	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs576146409	chr6:27178197-27178198	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs541092839	chr6:27178236-27178237	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs191064246	chr6:27178315-27178316	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs562270369	chr6:27178382-27178383	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs574228407	chr6:27178413-27178414	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs4577792	chr6:27178446-27178447	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs7450427	chr6:27178448-27178449	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs858986	chr6:27178523-27178524	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs375719700	chr6:27178550-27178551	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs529217424	chr6:27178556-27178557	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs563191130	chr6:27178564-27178565	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs36031380	chr6:27178650-27178651	Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs564675444	chr6:27178674-27178675	Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs858987	chr6:27178712-27178713	Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs183184284	chr6:27178745-27178746	Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs34723862	chr6:27178789-27178790	Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs11381697	chr6:27178796-27178797	Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs397974028	chr6:27178803-27178804	Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs563434840	chr6:27178822-27178823	Weak transcription Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs529297226	chr6:27178829-27178830	Weak transcription Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs187290686	chr6:27178830-27178831	Weak transcription Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs568300149	chr6:27178875-27178876	Weak transcription Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs534063090	chr6:27178924-27178925	Weak transcription Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs200981695	chr6:27178953-27178954	Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs12206886	chr6:27178954-27178955	Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs568137499	chr6:27178972-27178973	Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs547274395	chr6:27179051-27179052	Weak transcription Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs570617974	chr6:27179069-27179070	Weak transcription Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs146914051	chr6:27179096-27179097	Weak transcription Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs371967113	chr6:27179127-27179128	Weak transcription Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs858988	chr6:27179195-27179196	Weak transcription Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs191381254	chr6:27179204-27179205	Weak transcription Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs535476949	chr6:27179240-27179241	Weak transcription Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs79962815	chr6:27179301-27179302	Weak transcription Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs572672171	chr6:27179318-27179319	Weak transcription Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs183956948	chr6:27179359-27179360	Weak transcription Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD

Chromatin state (count:66 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:27174000-27179600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr6:27174400-27179000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr6:27174400-27181400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr6:27176400-27178000	Active TSS	ES-I3 Cell Line	embryonic stem cell
5	chr6:27176800-27178000	Enhancers	GM12878-XiMat	blood
6	chr6:27177000-27181000	Weak transcription	HUES48 Cell Line	embryonic stem cell
7	chr6:27177200-27178000	Flanking Active TSS	K562	blood
8	chr6:27177200-27181200	Weak transcription	HUES64 Cell Line	embryonic stem cell
9	chr6:27177200-27181400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
10	chr6:27177400-27178000	Active TSS	H9 Cell Line	embryonic stem cell
11	chr6:27177400-27178200	Active TSS	iPS-15b Cell Line	embryonic stem cell
12	chr6:27177600-27178000	Active TSS	H1 Cell Line	embryonic stem cell
13	chr6:27177600-27178000	Active TSS	HUES6 Cell Line	embryonic stem cell
14	chr6:27177800-27178000	Flanking Active TSS	Placenta	Placenta
15	chr6:27178000-27179000	Active TSS	Placenta	Placenta
16	chr6:27178000-27180600	Weak transcription	K562	blood
17	chr6:27178000-27181200	Weak transcription	H9 Cell Line	embryonic stem cell
18	chr6:27178000-27181400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
19	chr6:27178000-27181600	Weak transcription	GM12878-XiMat	blood
20	chr6:27178200-27179000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
21	chr6:27179000-27179400	Flanking Bivalent TSS/Enh	Placenta	Placenta
22	chr6:27179000-27179600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr6:27179000-27180000	Enhancers	iPS-15b Cell Line	embryonic stem cell
24	chr6:27179400-27179600	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
25	chr6:27179400-27180000	Bivalent Enhancer	Placenta	Placenta
26	chr6:27179600-27180000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
27	chr6:27179600-27182000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr6:27180000-27181400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
29	chr6:27180000-27181400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
30	chr6:27180400-27180600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr6:27180400-27180600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr6:27180600-27183600	Active TSS	K562	blood
33	chr6:27181000-27183000	Active TSS	A549	lung
34	chr6:27181000-27183400	Active TSS	HUES48 Cell Line	embryonic stem cell
35	chr6:27181000-27183400	Active TSS	iPS-20b Cell Line	embryonic stem cell
36	chr6:27181200-27183000	Bivalent/Poised TSS	Placenta	Placenta
37	chr6:27181200-27183200	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
38	chr6:27181200-27183400	Active TSS	H1 Cell Line	embryonic stem cell
39	chr6:27181200-27183400	Active TSS	H9 Cell Line	embryonic stem cell
40	chr6:27181200-27183400	Active TSS	HUES64 Cell Line	embryonic stem cell
41	chr6:27181400-27181600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
42	chr6:27181400-27181600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
43	chr6:27181400-27182400	Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr6:27181400-27183000	Active TSS	ES-WA7 Cell Line	embryonic stem cell
45	chr6:27181400-27183000	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
46	chr6:27181400-27183000	Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
47	chr6:27181400-27183000	Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
48	chr6:27181400-27183000	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
49	chr6:27181400-27183000	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr6:27181400-27183000	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links